U.S. officials and Libyan militiamen met to discuss the deteriorating security in Benghazi just two days before the attack that killed Ambassador Chris Stevens and three other Americans. Stevens is shown here at the consulate in June.
Two days before the deadly Sept. 11 attack on Americans in Libya, three U.S. officials met pro-government militias working to provide security in the city of Benghazi.
In that meeting, which included the American economic and political counselors, Mohammed el Gharabi, a leader of a prominent militia, says he warned the Americans that the security situation in Benghazi was deteriorating.
Assassinations are becoming rampant; no one is safe, including militiamen like himself, he says he told the Americans.
A Libyan follower of Ansar al-Sharia Brigades carries a placard reads in Arabic "our Islamic holies are red line," during a protest in front of the Tibesti Hotel, in Benghazi, Libya, on Sept. 14, as part of widespread anger across the Muslim world about a film ridiculing Islam's Prophet Muhammad.
Ansar al-Sharia, the ultraconservative armed Islamist group accused of taking part in the attack that killed the U.S. ambassador and three other Americans in Benghazi, Libya, denies it was involved. But the group's leadership stopped short of condemning the deadly attack. A top U.S. counterterrorism official says they are looking at the group in connection with the assault.
Ansar al-Sharia is one of the most powerful Islamist militias in eastern Libya. The brigade claims hundreds of men who fought, with U.S. and NATO support, to unseat strongman Moammar Gadhafi last year.
Originally published on Wed September 19, 2012 5:39 pm
By Michaeleen Doucleff
Ayo Bello grabs a box of malaria medication at a pharmacy in Lagos, Nigeria. A pilot project by the Global Fund has helped private pharmacies and clinics sell top quality malaria drugs at wholesale prices in Nigeria and seven other African countries.
Credit Sunday Alamba / Associated Press
Two years ago the United Nations' Global Fund launched an experiment that aimed to reduce the cost of malaria drugs in parts of Africa where they're needed most.
The idea was to subsidize the cost of drugs, sometimes making them available even cheaper than wholesale.
Did it work? The results for the first phase of the pilot were unveiled yesterday in Washington, and they looked pretty good — at least for the short time the project has been up and running.
In the U.S., the pap smear has become a routine part of women's health care, and it's dramatically reduced cervical cancer deaths. But in Africa and other impoverished regions, few women get pap smears because the countries lack the laboratories and other resources necessary to offer them.